Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI 		Symbol Lookup | Financial Search
THLD > SEC Filings for THLD > Form 8-K on 9-Oct-2009All Recent SEC Filings

Show all filings for THRESHOLD PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for THRESHOLD PHARMACEUTICALS INC

9-Oct-2009

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events

On October 8, 2009, Threshold Pharmaceuticals, Inc. ("Threshold") issued a press release announcing clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the Perspectives in Melanoma XIII Conference taking place in Baltimore, Maryland from October 8 to 10, 2009. A copy of Threshold's press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.



Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1 Press Release dated October 8, 2009

  Add THLD to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for THLD - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.